Pharmacy Compounding Advisory Committee backs use of compounded glutathione

In a vote that ran counter to expectations, the Pharmacy Compounding Advisory Committee (PCAC) – the group that advises the U.S. Food and Drug Administration (FDA) on drug compounding issues – put its stamp of approval on compounded glutathione. PCAC uncharacteristically rejected the FDA staff’s recommendation to ban the substance for compounding purposes and told the governing body that the substance, which is widely used by integrative practitioners, should be placed on the approved list for…